• Trials and Research

  Blood stem cell transplant could be better than DMDs for treating highly active RRMS

  Posted by ms-news-today-moderator on April 24, 2018 at 5:03 pm

  Autologous non-myeloablative hematopoietic stem cell transplant was found to be better at reducing risks for disability in patients with relapsing-remitting multiple sclerosis compared to disease-modifying drug (DMD) therapies.

  Read more about it here: #AAN2018 – Blood Stem Cell Transplant Superior to DMDs in Highly Active RRMS, MIST Trial Shows

  What do you think about this?

  replied 5 years, 12 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply